| Views | |
|---|---|
| Daratumumab for treatment‐refractory antibody‐mediated diseases in neurology | 95 |
| April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | |
|---|---|---|---|---|---|---|---|
| Daratumumab for treatment‐refractory antibody‐mediated diseases in neurology | 3 | 14 | 5 | 7 | 12 | 18 | 25 |
| Views | |
|---|---|
| 2022_Scheibe_etal.pdf | 29 |
